Literature DB >> 8148437

Viral studies of chronic fatigue syndrome.

J A Levy1.   

Abstract

Chronic fatigue syndrome (CFS) has many characteristics suggesting persistent fatigue following a viral illness. At least nine different RNA and DNA viruses have been considered to be associated with this disease, but none of these viruses has been found to be the etiologic agent. Immunologic studies have demonstrated activated CD8+ cells and reduced function of natural killer cells suggesting a host response to an infection that has led to persistent immune disorders. Some of the symptoms of CFS may be due to cytokines produced by this hyperactive immune response to a virus that is still present in the host or that has been eliminate but leaves abnormal immunologic sequelae. These possibilities offer directions for future studies of CFS and therapeutic approaches to this condition.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148437     DOI: 10.1093/clinids/18.supplement_1.s117

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  7 in total

1.  TNF-alpha and chronic fatigue syndrome.

Authors:  R B Moss; A Mercandetti; A Vojdani
Journal:  J Clin Immunol       Date:  1999-09       Impact factor: 8.317

Review 2.  Chronic fatigue syndrome: probable pathogenesis and possible treatments.

Authors:  Birgitta Evengård; Nancy Klimas
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 3.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

4.  Human herpesviruses in chronic fatigue syndrome.

Authors:  H L Wallace; B Natelson; W Gause; J Hay
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

5.  Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Samuel Yoo; Shaun Bhatia
Journal:  Chronic Illn       Date:  2021-09-20

6.  Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.

Authors:  F Mensah; A Bansal; S Berkovitz; A Sharma; V Reddy; M J Leandro; G Cambridge
Journal:  Clin Exp Immunol       Date:  2016-02-22       Impact factor: 4.330

7.  Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.

Authors:  Shigeyuki Yamamoto; Yasuomi Ouchi; Daisaku Nakatsuka; Tsuyoshi Tahara; Kei Mizuno; Seiki Tajima; Hirotaka Onoe; Etsuji Yoshikawa; Hideo Tsukada; Masao Iwase; Kouzi Yamaguti; Hirohiko Kuratsune; Yasuyoshi Watanabe
Journal:  PLoS One       Date:  2012-12-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.